With new investigational therapies and disruptive technology, TriSalus Life Sciences is seeking to enable more patients living with liver and pancreatic tumors to benefit from immunotherapy. SIO is teaming up with TriSalus to host an hour-long webinar that will explore the current scientific understanding of the treatment barriers that have limited the efficacy of immunotherapy for liver and pancreatic tumors.